Mingzhou Ye

1.9k total citations
26 papers, 1.6k citations indexed

About

Mingzhou Ye is a scholar working on Biomedical Engineering, Materials Chemistry and Biomaterials. According to data from OpenAlex, Mingzhou Ye has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomedical Engineering, 10 papers in Materials Chemistry and 8 papers in Biomaterials. Recurrent topics in Mingzhou Ye's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Dendrimers and Hyperbranched Polymers (5 papers). Mingzhou Ye is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Dendrimers and Hyperbranched Polymers (5 papers). Mingzhou Ye collaborates with scholars based in China, United States and New Zealand. Mingzhou Ye's co-authors include Shaoqin Gong, Ruosen Xie, Yuyuan Wang, Yi Zhao, Youqing Shen, Jianbin Tang, Nisakorn Yodsanit, Yuxin Han, Zhuxian Zhou and Xiangrui Liu and has published in prestigious journals such as Advanced Materials, Nature Nanotechnology and Advanced Functional Materials.

In The Last Decade

Mingzhou Ye

25 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingzhou Ye China 17 862 619 425 388 170 26 1.6k
Dinglin Zhang China 22 653 0.8× 624 1.0× 407 1.0× 415 1.1× 165 1.0× 56 1.7k
Yin‐Jia Cheng China 17 796 0.9× 532 0.9× 663 1.6× 348 0.9× 61 0.4× 46 1.4k
Leilei Shi China 24 792 0.9× 479 0.8× 364 0.9× 489 1.3× 80 0.5× 66 1.5k
Jiaul Islam Australia 4 936 1.1× 642 1.0× 946 2.2× 446 1.1× 139 0.8× 5 2.1k
Kye J. Robinson Switzerland 12 943 1.1× 674 1.1× 961 2.3× 475 1.2× 139 0.8× 21 2.2k
Xi Zhu China 17 597 0.7× 857 1.4× 492 1.2× 234 0.6× 121 0.7× 36 1.7k
Hao Cheng China 18 1.2k 1.3× 531 0.9× 491 1.2× 579 1.5× 85 0.5× 46 1.9k
Handan Acar United States 16 630 0.7× 693 1.1× 697 1.6× 335 0.9× 96 0.6× 27 1.7k
Wenjun Le China 17 839 1.0× 482 0.8× 440 1.0× 461 1.2× 83 0.5× 40 1.5k
Keni Yang China 15 810 0.9× 821 1.3× 793 1.9× 596 1.5× 177 1.0× 25 1.9k

Countries citing papers authored by Mingzhou Ye

Since Specialization
Citations

This map shows the geographic impact of Mingzhou Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzhou Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzhou Ye more than expected).

Fields of papers citing papers by Mingzhou Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzhou Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzhou Ye. The network helps show where Mingzhou Ye may publish in the future.

Co-authorship network of co-authors of Mingzhou Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzhou Ye. A scholar is included among the top collaborators of Mingzhou Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzhou Ye. Mingzhou Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jia, et al.. (2025). Advances in hydrogel drug delivery systems for myocardial infarction treatment. Journal of Zhejiang University (Medical Sciences). 54(4). 455–468.
2.
Shao, Weidong, et al.. (2025). Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling. Stem Cell Research & Therapy. 16(1). 27–27. 11 indexed citations
3.
Xie, Ruosen, Ruixuan Gao, Yi Zhao, et al.. (2024). Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections. Nature Nanotechnology. 19(7). 1032–1043. 51 indexed citations
4.
Ye, Mingzhou, Yi Zhao, Yuyuan Wang, et al.. (2022). NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis. Nature Nanotechnology. 17(8). 880–890. 110 indexed citations
5.
Zhao, Yi, Takuro Shirasu, Nisakorn Yodsanit, et al.. (2021). Biomimetic, ROS-detonable nanoclusters — A multimodal nanoplatform for anti-restenotic therapy. Journal of Controlled Release. 338. 295–306. 23 indexed citations
6.
Ye, Mingzhou, Yi Zhao, Yuyuan Wang, et al.. (2021). A Dual‐Responsive Antibiotic‐Loaded Nanoparticle Specifically Binds Pathogens and Overcomes Antimicrobial‐Resistant Infections. Advanced Materials. 33(9). e2006772–e2006772. 134 indexed citations
7.
Zhao, Yi, Ruosen Xie, Nisakorn Yodsanit, et al.. (2021). Hydrogen peroxide-responsive platelet membrane-coated nanoparticles for thrombus therapy. Biomaterials Science. 9(7). 2696–2708. 49 indexed citations
8.
Zhao, Yi, Ruosen Xie, Nisakorn Yodsanit, et al.. (2020). Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy. Nano Today. 35. 100986–100986. 97 indexed citations
9.
Ye, Mingzhou, Yi Zhao, Yuyuan Wang, et al.. (2020). pH‐Responsive Polymer–Drug Conjugate: An Effective Strategy to Combat the Antimicrobial Resistance. Advanced Functional Materials. 30(39). 83 indexed citations
10.
Patel, Ravi B., Mingzhou Ye, Peter M. Carlson, et al.. (2019). Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles. Advanced Materials. 31(43). e1902626–e1902626. 189 indexed citations
11.
Ye, Mingzhou & Shaoqin Gong. (2019). Drug Loaded Adipocytes: Sugar-Coated Bullets for Cancer. Matter. 1(5). 1104–1105. 4 indexed citations
12.
Yu, Wei, Mingzhou Ye, Jian Zhu, et al.. (2018). Zinc phthalocyanine encapsulated in polymer micelles as a potent photosensitizer for the photodynamic therapy of osteosarcoma. Nanomedicine Nanotechnology Biology and Medicine. 14(4). 1099–1110. 49 indexed citations
13.
Wang, Yuyuan, Mingzhou Ye, Ruosen Xie, & Shaoqin Gong. (2018). Enhancing the In Vitro and In Vivo Stabilities of Polymeric Nucleic Acid Delivery Nanosystems. Bioconjugate Chemistry. 30(2). 325–337. 66 indexed citations
14.
Ye, Mingzhou, Yuxin Han, Jianbin Tang, et al.. (2017). A Tumor‐Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers. Advanced Materials. 29(38). 309 indexed citations
15.
Hu, Hongjie, Yuqi Sheng, Mingzhou Ye, et al.. (2016). A porphyrin-based magnetic and fluorescent dual-modal nanoprobe for tumor imaging. Polymer. 88. 94–101. 16 indexed citations
16.
Ye, Mingzhou, Jianbin Tang, Zhiqian Guo, et al.. (2016). Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapy. Chemical Science. 7(8). 4958–4965. 141 indexed citations
17.
Han, Yuxin, Mingzhou Ye, Jianbin Tang, et al.. (2015). Synthesis and properties of zwitterionic dendrimer as drug and imaging probe carrier. Journal of Controlled Release. 213. e144–e145. 1 indexed citations
18.
Li, Tingting, Yue Qian, Mingzhou Ye, et al.. (2014). Synthesis and Properties of a Biodegradable Dendritic Magnetic Resonance Imaging Contrast Agent. Chinese Journal of Chemistry. 32(1). 91–96. 11 indexed citations
19.
Ye, Mingzhou, Yue Qian, Jianbin Tang, et al.. (2013). Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging. Journal of Controlled Release. 169(3). 239–245. 59 indexed citations
20.
Ye, Mingzhou, Jianbin Tang, Xingping Wang, et al.. (2011). Synthesis and characterization of a novel dendritic magnetic resonance imaging contrast agent. Journal of Controlled Release. 152. e256–e257. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026